Bioactivity of Three Salvia Species in Relation to Their Total Phenolic and Flavonoid Contents


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Antioxidant, anti-inflammatory, cytotoxic activities and total phenolic and flavonoid contents of methanol extracts of three Salvia species including Salvia discolor, S. officinalis and S. sclarea were investigated. The compositions of extracts were analyzed by high performance liquid chromatography (HPLC) with a UV-DAD detector. The major component of extracts from aerial parts of Salvia species was rosmarinic acid (0.2 – 61.1%). The composition of methanol extract from aerial parts strongly differed from that of the root extract. The total phenolic and flavonoid contents per 100 g fresh weight ranged within 658.3 – 1805.9 mg of caffeic acid equivalent (CAE) and 13.0 – 184.9 mg of quercetin equivalent (QE), respectively. The highest DPPH radical scavenging effect was observed for S. sclarea extract (with an IC50 of 21.6 μg/mL), while S. discolour extract exhibited the highest ABTS•+ radical scavenging ability (with IC50 of 53.0 μg/mL) among all extracts. All Salvia extracts showed remarkable cytotoxic effect toward human T-lymphoblast leukemia (CCRF-CEM) and adriamycin resistant leukemia (CEM/ADR 5000) with average IC50 values of 25.3 – 65 μg/mL and 34.5 – 89.8 μg/mL, respectively. A relatively strong effect against human breast adenocarcinoma (MCF-7) was observed for the S. officinalis extract, with an IC50 of 138.5 μg/mL.

About the authors

Farukh Sharopov

Institute of Pharmacy and Molecular Biotechnology, Heidelberg University; Department of Pharmaceutical Technology, Avicenna Tajik State Medical University

Author for correspondence.
Email: shfarukh@mail.ru
Germany, Im Neuenheimer Feld 364, Heidelberg, D-69120; Rudaki 139, Dushanbe, 734003

Abdujabbor Valiev

Department of Pharmaceutical Technology, Avicenna Tajik State Medical University

Email: wink@uni-hd.de
Tajikistan, Rudaki 139, Dushanbe, 734003

Mansour Sobeh

Institute of Pharmacy and Molecular Biotechnology, Heidelberg University

Email: wink@uni-hd.de
Germany, Im Neuenheimer Feld 364, Heidelberg, D-69120

Eva Arnold

Institute of Pharmacy and Molecular Biotechnology, Heidelberg University

Email: wink@uni-hd.de
Germany, Im Neuenheimer Feld 364, Heidelberg, D-69120

Michael Winka

Institute of Pharmacy and Molecular Biotechnology, Heidelberg University

Author for correspondence.
Email: wink@uni-hd.de
Germany, Im Neuenheimer Feld 364, Heidelberg, D-69120


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies